Cargando…
Mesenchymal Stem Cells as a Cornerstone in a Galaxy of Intercellular Signals: Basis for a New Era of Medicine
Around 40% of the population will suffer at some point in their life a disease involving tissue loss or an inflammatory or autoimmune process that cannot be satisfactorily controlled with current therapies. An alternative for these processes is represented by stem cells and, especially, mesenchymal...
Autores principales: | Fernández-Francos, Silvia, Eiro, Noemi, Costa, Luis A., Escudero-Cernuda, Sara, Fernández-Sánchez, María Luisa, Vizoso, Francisco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036553/ https://www.ncbi.nlm.nih.gov/pubmed/33808241 http://dx.doi.org/10.3390/ijms22073576 |
Ejemplares similares
-
Importance of the origin of mesenchymal (stem) stromal cells in cancer biology: “alliance” or “war” in intercellular signals
por: Eiro, Noemi, et al.
Publicado: (2021) -
Mesenchymal Stem/Stromal Cells and Their Derivates in Acute Diseases: Emergency in the Post-COVID-19 Times
por: Vizoso, Francisco J., et al.
Publicado: (2021) -
Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives
por: Fernández-Francos, Silvia, et al.
Publicado: (2021) -
Joint Tumor Bud–MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma
por: González, Luis O., et al.
Publicado: (2021) -
Towards a New Concept of Regenerative Endodontics Based on Mesenchymal Stem Cell-Derived Secretomes Products
por: Costa, Luis A., et al.
Publicado: (2022)